Neutralization of TNF does not influence endotoxin-induced changes in thyroid hormone metabolism in humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 2 45-2, 1999, Pages

  Van Der Poll, Tom ^a,b   Endert, Erik ^b   Coyle, Susette M ^a   Agosti, Jan M ^c   Lowry, Stephen F ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c AMGEN INC   (United States)

Author keywords

Cytokines; Lipopolysaccharide; Thyrotropin

Indexed keywords

THYROID HORMONE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; ENDOTOXEMIA; EUTHYROID SICK SYNDROME; HUMAN; LIOTHYRONINE BLOOD LEVEL; MALE; PRIORITY JOURNAL; THYROID HORMONE METABOLISM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0033053024     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.2.r357     Document Type: Article

References (37)

1. Boelen, A., M. A. W. Maas, C. W. G. Lowik, M. C. Platvoet, and W. M. Wiersinga. Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3′-triiodothyronine syndrome. Endocrinology 137: 5250-5254, 1996.
2. Buscema, M., I. Todd, U. Deuss, L. Hammond, R. Mirakian, R. Pujol-Borrell, and G. F. Botazzo. Influence of tumor necrosis factor-α on the modulation by Interferon-γ of HLA class II molecules in human thyroid cells and its effect on Interferon-γ binding. J. Clin. Endocrinol. Metab. 69: 433-439, 1989.
3. Corssmit, E. P. M., R. Heyligenberg, E. Endert, H. P. Sauerwein, and J. A. Romijn. Acute effects of interferon-α administration on thyroid hormone metabolism in healthy men. J. Clin. Endocrinol. Metab. 80: 3140-3144, 1995.
4. Danford, E. Effects of fasting and altered nutrition on thyroid hormone metabolism in man. In: Thyroid Hormone Metabolism, edited by G. Henneman. New York: Dekker, 1986, p. 335-358.
5. Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147, 1996.
6. Evans, T. J., D. Moyes, A. Carpenter, R. Martin, H. Loetscher, W. Lesslauer, and J. Cohen. Protective effect of 55-but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of Gram-negative sepsis. J. Exp. Med. 180: 2173-2179, 1994.
7. Hershman, J. M., and X. P. Pang. Action of tumor necrosis factor-α on thyroid cells. Trans. Am. Clin. Climatol. Assoc. 105: 131-143, 1993.
8. Kaptein, E. M. Thyroid hormone metabolism in illness. In: Thyroid Hormone Metabolism, edited by G. Henneman. New York: Dekker, 1986, p. 297-333.
9. Mohler, K. M., D. S. Torrance, C. A. Smith, R. G. Goodwin, K. E. Stremler, V. P. Fung, H. Madani, and M. B. Widmer. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151: 1548-1561, 1993.
10. Ongphiphadhanakul, B., S. L. Fang, K. T. Tang, N. A. Patwardhan, and L. E. Braverman. Tumor necrosis factor-α decreases thyrotropin-induced 5′-deiodinase activity in FRTL-5 thyroid cells. Eur. J. Endocrinol. 130: 502-507, 1994.
11. Ozawa, M., K. Sato, D. C. Han, M. Kawakami, O. Tsushima, and K. Shizume. Effects of tumor necrosis factor-α/cachectin on thyroid hormone metabolism in mice. Endocrinology 123: 1461-1467, 1988.
12. Pang, X. P., J. M. Hershman, M. Chung, and M. E. Pekary. Characterization of tumor necrosis factor-α receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology 125: 1783-1788, 1989.
13. Pang, X. P., J. M. Hershman, C. J. Mirell, and A. E. Pekary. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-α (cachectin). Endocrinology 125: 76-84, 1989.
14. Pang, X. P., J. M. Hershman, V. Smith, A. E. Pekary, and M. Sugawara. The mechanism of action of tumour necrosis factor-α and interleukin-1 on FRTL-5 rat thyroid cells. Acta Endocrinol. 123: 203-210, 1990.
15. Pang, X. P., M. Yoshimura, and J. M. Hershman. Suppression of rat thyrotroph and thyroid cell function by tumor necrosis factor-α. Thyroid 3: 325-330, 1993.
16. Pekary, A. E., L. Berg, F. Santini, I. Chopra, and J. M. Hershman. Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells. Mol. Cell. Endocrinol. 101: R31-R35, 1994.
17. Pekary, A. E., I. Chopra, L. Berg, and J. M. Hershman. Sphingomyelinase and phospholipase A2 regulate type I deiodinase expression in FRTL-5 cells. Thyroid 7: 647-654, 1997.
18. Pekary, A. E., and J. M. Hershman. Tumor necrosis factor, ceramide, transforming growth factor-1, and aging reduce Na+/I-symporter messenger ribonucleic acid levels in FRT L-5 cells. Endocrinology 139: 703-712, 1998.
19. Pekary, A. E., S. R. Levin, D. G. Johnson, L. Berg, and J. M. Hershman. Tumor necrosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β1) inhibit the expression and activity of Na+/K(+)-ATPase in FRLT-5 rat thyroid cells. J. Interferon Cytokine Res. 17: 185-195, 1997.
20. Rasmussen, A. K., L. Kayser, U. Feldt-Rasmussen, and K. Bendtzen. Influence of tumour necrosis factor-α, tumour necrosis factor-β and interferon-γ, separately and added together with interleukin-1β, on the function of cultured human thyroid cells. J. Endocrinol. 143: 359-365, 1994.
21. Romijn, J. A., and W. M. Wiersinga. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J. Clin. Endocrinol. Metab. 70: 35-42, 1990.
22. 125I organification and thyroid hormone release by interleukin 1, tumor necrosis factor α and Interferon-γ in human thyrocytes in suspension culture. J. Clin. Endocrinol. Metab. 70: 1735-1743, 1990.
23. Stouthard, J. M. L., T. van der Poll, E. Endert, P. J. M. Bakker, C. H. N. Veenhof, H. P. Sauerwein, and J. A. Romijn. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J. Clin. Endocrinol. Metab. 79: 1342-1346, 1994.
24. Suffredini, A. F., D. Reda, S. M. Banks, M. Tropea, J. M. Agosti, and R. Miller. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J. Immunol. 155: 5038-5045, 1995.
25. Tang, K. T., L. E. Braverman, and W. J. De Vito. Tumor necrosis factor-α and interferon-γ modulate gene expression of type I 5′-deiodinase, thyroid peroxidase, and thyroglobulin in FRTL-5 rat thyroid cells. Endocrinology 136: 881-888, 1995.
26. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664, 1987.
27. Van der Poll, T., S. M. Coyle, A. Kumar, K. Barbosa, J. Agosti, and S. F. Lowry. Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia. Effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor. J. Immunol. 158: 1490-1497, 1997.
28. Van der Poll, T., S. M. Coyle, M. Levi, P. M. Jansen, M. Dentener, K. Barbosa, W. A. Buurman, C. E. Hack, J. W. ten Cate, J. M. Agosti, and S. F. Lowry. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 89: 3727-3734, 1997.
29. Van der Poll, T., M. Levi, S. J. H. van Deventer, H. ten Cate, B. L. Haagmans, B. J. Biemond, H. R. Büller, C. E. Hack, and J. W. ten Cate. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 83: 446-451, 1994.
30. Van der Poll, T., and S. F. Lowry. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 3: 1-12, 1995.
31. Van der Poll, T., and S. F. Lowry. Biological responses to endotoxin in humans. In: Modulation of the Inflammatory Response in Severe Sepsis, edited by J. M. Tellado, R. A. Forse, and J. S. Solomkin. Basel, Switzerland: Karger, 1995, p. 18-32.
32. Van der Poll, T., J. A. Romijn, W. M. Wiersinga, and H. P. Sauerwein. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J. Clin. Endocrinol. Metab. 71: 1567-1572, 1990.
33. Van der Poll, T., K. J. van Zee, E. Endert, S. M. Coyle, D. M. Stiles, J. P. Pribble, M. A. Catalano, L. L. Moldawer, and S. F. Lowry. Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J. Clin. Endocrinol. Metab. 80: 1341-1346, 1995.
34. Wartofsky, L., and K. D. Burman. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome." Endocr. Rev. 3: 164-217, 1982.
35. Wehmann, R. E., R. I. Gregerman, W. H. Burns, R. Saral, and G. W. Santos. Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N. Engl. J. Med. 312: 546-552, 1985.
36. Wiersinga, W. M., and I. J. Chopra. Radioimmunoassays of thyroxine (T4), 3,5,3′-triiodothyronine (T3), 3,3′,5′-triiodothyronine (rT3), and 3,3′-diiodothyronine (T2). Methods Enzymol. 84: 272-303, 1982.
37. Zheng, R. Q. H., E. R. Abney, C. Q. Chu, M. Field, R. N. Maini, and J. R. Lamb. Detection of in vivo production of tumour necrosis factor-a by human thyroid epithelial cells. Immunology 75: 456-462, 1992.